MX9204425A - Derivados de quinazolina como inhibidores de la acetilcolinesterasa. - Google Patents
Derivados de quinazolina como inhibidores de la acetilcolinesterasa.Info
- Publication number
- MX9204425A MX9204425A MX9204425A MX9204425A MX9204425A MX 9204425 A MX9204425 A MX 9204425A MX 9204425 A MX9204425 A MX 9204425A MX 9204425 A MX9204425 A MX 9204425A MX 9204425 A MX9204425 A MX 9204425A
- Authority
- MX
- Mexico
- Prior art keywords
- quinazoline derivatives
- acetylcholinesterase inhibitors
- acetylcholinesterase
- inhibitors
- quinazoline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73688891A | 1991-07-29 | 1991-07-29 | |
US91166292A | 1992-07-16 | 1992-07-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9204425A true MX9204425A (es) | 1993-01-01 |
Family
ID=27113138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9204425A MX9204425A (es) | 1991-07-29 | 1992-07-29 | Derivados de quinazolina como inhibidores de la acetilcolinesterasa. |
Country Status (13)
Country | Link |
---|---|
US (1) | US5486512A (es) |
EP (1) | EP0597956A1 (es) |
JP (1) | JPH06509576A (es) |
AU (1) | AU665207B2 (es) |
CA (1) | CA2113115A1 (es) |
CZ (1) | CZ281628B6 (es) |
FI (1) | FI940393A (es) |
HU (1) | HUT66324A (es) |
IE (1) | IE922434A1 (es) |
MX (1) | MX9204425A (es) |
NO (1) | NO940305L (es) |
PT (1) | PT100742A (es) |
WO (1) | WO1993003034A1 (es) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030153598A1 (en) * | 2000-07-25 | 2003-08-14 | Raymond Pratt | Methods for treating Parkinson's disease with cholinesterase inhibitors |
PT1311272E (pt) * | 2000-03-03 | 2007-02-28 | Eisai R&D Man Co Ltd | Novos métodos utilizando inibidores de colinesterase |
IL149357A0 (en) * | 2000-09-07 | 2002-11-10 | Bayer Ag | Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
US7022844B2 (en) | 2002-09-21 | 2006-04-04 | Honeywell International Inc. | Amide-based compounds, production, recovery, purification and uses thereof |
DK1746999T3 (da) * | 2004-05-06 | 2012-01-23 | Warner Lambert Co | 4-phenylamino-quinazolin-6-yl-amider |
WO2006071274A2 (en) * | 2004-12-23 | 2006-07-06 | Voyager Pharmaceutical Corporation | Leuprolide acetate and acetylcholinesterase inhibitors or nmda receptor antagonists for the treatment of alzheimer’s disease |
EP1910367A2 (en) * | 2005-05-20 | 2008-04-16 | Alantos Pharmaceuticals, Inc. | Pyrimidine or triazine fused bicyclic metalloprotease inhibitors |
US20070155738A1 (en) * | 2005-05-20 | 2007-07-05 | Alantos Pharmaceuticals, Inc. | Heterobicyclic metalloprotease inhibitors |
EP2089383B1 (en) | 2006-11-09 | 2015-09-16 | Probiodrug AG | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
ATE554085T1 (de) | 2006-11-30 | 2012-05-15 | Probiodrug Ag | Neue inhibitoren von glutaminylcyclase |
MX2009009234A (es) | 2007-03-01 | 2009-12-01 | Probiodrug Ag | Uso nuevo de inhibidores de ciclasa de glutaminilo. |
WO2008128985A1 (en) | 2007-04-18 | 2008-10-30 | Probiodrug Ag | Thiourea derivatives as glutaminyl cyclase inhibitors |
CN101220043A (zh) * | 2008-01-24 | 2008-07-16 | 沈阳药科大学 | 噻唑并[3,2-a]嘧啶类衍生物及其应用 |
KR101755737B1 (ko) | 2009-09-11 | 2017-07-07 | 프로비오드룩 아게 | 글루타미닐 사이클라제의 억제제로서 헤테로사이클릭 유도체 |
EA037187B1 (ru) | 2010-02-09 | 2021-02-17 | Дзе Джонс Хопкинс Юниверсити | Способ и композиция для лечения когнитивного расстройства |
US9181233B2 (en) | 2010-03-03 | 2015-11-10 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
CA2789440C (en) | 2010-03-10 | 2020-03-24 | Probiodrug Ag | Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
JP5945532B2 (ja) | 2010-04-21 | 2016-07-05 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体 |
ES2570167T3 (es) | 2011-03-16 | 2016-05-17 | Probiodrug Ag | Derivados de benzimidazol como inhibidores de glutaminil ciclasa |
US10154988B2 (en) | 2012-11-14 | 2018-12-18 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
JP6669499B2 (ja) | 2013-02-15 | 2020-03-18 | カラ ファーマシューティカルズ インコーポレイテッド | 治療用化合物 |
US9688688B2 (en) | 2013-02-20 | 2017-06-27 | Kala Pharmaceuticals, Inc. | Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof |
US9353123B2 (en) | 2013-02-20 | 2016-05-31 | Kala Pharmaceuticals, Inc. | Therapeutic compounds and uses thereof |
WO2014144663A1 (en) | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
WO2014144801A1 (en) | 2013-03-15 | 2014-09-18 | Agenebio Inc. | Methods and compositions for improving cognitive function |
US9890173B2 (en) | 2013-11-01 | 2018-02-13 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
CN106061261B (zh) | 2013-11-01 | 2018-04-24 | 卡拉制药公司 | 治疗化合物的结晶形式及其用途 |
US10925834B2 (en) | 2015-05-22 | 2021-02-23 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
JP6745824B2 (ja) | 2015-06-26 | 2020-08-26 | 武田薬品工業株式会社 | 複素環化合物 |
JP6787913B2 (ja) * | 2015-10-20 | 2020-11-18 | 武田薬品工業株式会社 | 複素環化合物 |
AU2017324716B2 (en) | 2016-09-08 | 2020-08-13 | KALA BIO, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
US10253036B2 (en) | 2016-09-08 | 2019-04-09 | Kala Pharmaceuticals, Inc. | Crystalline forms of therapeutic compounds and uses thereof |
EP3509421A4 (en) | 2016-09-08 | 2020-05-20 | Kala Pharmaceuticals, Inc. | CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF |
ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2992221A (en) * | 1958-07-03 | 1961-07-11 | Petersen Siegfried | Polymethylene-oxoquinazolines and their production |
US3271396A (en) * | 1964-08-17 | 1966-09-06 | Squibb & Sons Inc | Pyrido-quinazoline derivatives |
US3745216A (en) * | 1969-12-18 | 1973-07-10 | Smith Kline French Lab | Compositions and methods for producing hypotensive activity with imidazo and pyrimido(2,1-b)quinazoline compounds |
US3932407A (en) * | 1973-11-19 | 1976-01-13 | Bristol-Myers Company | Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones |
BE794964A (fr) * | 1972-02-04 | 1973-08-02 | Bristol Myers Co | Nouveaux agents hypotenseurs et procede pour les preparer |
JPS5752352B2 (es) * | 1974-02-28 | 1982-11-06 | ||
NL7807507A (nl) * | 1977-07-25 | 1979-01-29 | Hoffmann La Roche | Tricyclische verbindingen. |
HU182009B (en) * | 1977-08-19 | 1983-12-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing substituted pirido-square bracket-1,2-a-square bracket closed-pyrimidines, pyrrolo-square bracket-1,2-a-square bracket closed-pyrimidines |
DE2845766A1 (de) * | 1978-10-18 | 1980-04-30 | Schering Ag | Pyrido eckige klammer auf 2,1-b eckige klammer zu -chinazolinon-derivate, ihre herstellung und verwendung |
AT377586B (de) * | 1981-06-30 | 1985-04-10 | Erba Farmitalia | Verfahren zur herstellung von substituierten pyrrolo-(2,1-b)-chinazolinen und pyrido(2,1-b)chinazolinen |
FR2512674B1 (fr) * | 1981-09-16 | 1986-01-10 | Sandoz Sa | Nouveaux derives tricycliques de la quinazolinone, leur preparation et medicaments contenant ces derives |
US4395554A (en) * | 1981-12-01 | 1983-07-26 | Mobil Oil Corporation | Process for producing alpha-picoline |
ES8607299A1 (es) * | 1984-02-15 | 1986-06-01 | Syntex Inc | Procedimiento para preparar (2-oxo-1,2,3,5-tetrahidroimida- zo(2,1-b)quinazolinil)-oxialquilamidas |
US4783467A (en) * | 1985-06-05 | 1988-11-08 | Pfizer Inc. | Tetrahydroimidazoquinazolinone inotropic agents |
US4837239A (en) * | 1985-08-23 | 1989-06-06 | Syntex (U.S.A.) Inc. | Cardiotonic phosphodiesterase inhibitors complexed with water soluble vitamins |
US4670434A (en) * | 1985-11-14 | 1987-06-02 | Syntex (U.S.A.) Inc. | (2-oxo-3-methylene-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolinyl)oxyalkylamides useful as cyclic AMP phosphodiesterase inhibitors |
US4766126A (en) * | 1986-01-10 | 1988-08-23 | Daiichi Seiyaku Co., Ltd. | Process for treatment of nephritis with imidazoquinazolines |
US4760065A (en) * | 1986-02-13 | 1988-07-26 | Hardtmann Goetz E | Trifluoromethyl substituted tetracyclic quinazolin-ones having tranquilizing activity |
-
1992
- 1992-07-22 AU AU23978/92A patent/AU665207B2/en not_active Ceased
- 1992-07-22 WO PCT/US1992/005864 patent/WO1993003034A1/en not_active Application Discontinuation
- 1992-07-22 JP JP5503581A patent/JPH06509576A/ja active Pending
- 1992-07-22 HU HU9400258A patent/HUT66324A/hu unknown
- 1992-07-22 CA CA002113115A patent/CA2113115A1/en not_active Abandoned
- 1992-07-22 EP EP92916726A patent/EP0597956A1/en not_active Withdrawn
- 1992-07-22 CZ CZ94135A patent/CZ281628B6/cs unknown
- 1992-07-24 IE IE243492A patent/IE922434A1/en not_active Application Discontinuation
- 1992-07-29 MX MX9204425A patent/MX9204425A/es unknown
- 1992-07-29 PT PT100742A patent/PT100742A/pt not_active Application Discontinuation
-
1994
- 1994-01-26 FI FI940393A patent/FI940393A/fi not_active Application Discontinuation
- 1994-01-28 NO NO940305A patent/NO940305L/no unknown
- 1994-03-17 US US08/214,911 patent/US5486512A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
FI940393A (fi) | 1994-03-11 |
CZ281628B6 (cs) | 1996-11-13 |
JPH06509576A (ja) | 1994-10-27 |
AU2397892A (en) | 1993-03-02 |
WO1993003034A1 (en) | 1993-02-18 |
PT100742A (pt) | 1993-10-29 |
HU9400258D0 (en) | 1994-06-28 |
IE922434A1 (en) | 1993-02-10 |
HUT66324A (en) | 1994-11-28 |
CA2113115A1 (en) | 1993-02-18 |
CZ13594A3 (en) | 1994-05-18 |
EP0597956A1 (en) | 1994-05-25 |
NO940305L (no) | 1994-03-28 |
US5486512A (en) | 1996-01-23 |
AU665207B2 (en) | 1995-12-21 |
FI940393A0 (fi) | 1994-01-26 |
NO940305D0 (no) | 1994-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9204425A (es) | Derivados de quinazolina como inhibidores de la acetilcolinesterasa. | |
MX9205678A (es) | Heteroarilaminas como nuevos inhibidores de la acetilcolinesterasa. | |
MX9201823A (es) | Derivados de quinolina. | |
TR27343A (tr) | Kinazolin türevleri. | |
TR199600265A1 (tr) | Kinazolin türevleri. | |
NO970501D0 (no) | Substituerte kinazolinderivater | |
DE59201977D1 (de) | Einmesser-Reibahle. | |
TR199600029A2 (tr) | 2,8-disübstitüe edilmis kinazolinonlar. | |
DE59501802D1 (de) | Substituierte 1H-3-Aryl-pyrrolidin-2,4-dion-Derivate | |
FI934610A0 (fi) | Ventilsammansaettning foer roerledning, omfattande loestagbart ventilsaete | |
MX9204190A (es) | Derivdos de 2-(4-hidroxipiperidino)-1-alcanol como agentes antiisquemicos. | |
TR27090A (tr) | Tetrahidropirimidin türevleri. | |
DE69017543D1 (de) | Acetylcholinesterase-Inhibitoren. | |
DE69110093D1 (de) | Pyrimidinderivate. | |
DE69003465D1 (de) | Chinazolinderivate. | |
FI932516A (fi) | Styrkonsol, i synnerhet foer motorfordon | |
DE69524611D1 (de) | Pyrimidon-derivate | |
FI931747A0 (fi) | Reflexkropp, isynnerhet foer vaegmarkeringar | |
FR2684583B1 (fr) | Alesoir conique. | |
FI922980A (fi) | 2-piperidinylpyrimidin-4-karboxamidderivat, framstaellning av dessa ochterapeutisk anvaendning av dessa | |
DE69004844D1 (de) | Pyrimidin-Derivate. | |
FI923542A (fi) | Faestanordning foer klingor, isynnerhet i bestrykningsmaskiner | |
FI934317A (fi) | Farmaceutiska sammansaettningar, vilka innehaoller ej-joniska ytaktiva aemnen | |
FI935130A0 (fi) | Raelsbund vagn med skjuttak, saerskilt foer biltransport | |
FI266U1 (fi) | Kapningsanordning foer aemnesbana, saosom en pappersbana |